The US Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in ...

Parkinson's Disease Treatment Market Aging Populations and Advancements in Deep Brain Stimulation, Gene Therapy, and Medications Fuel Marke ...

Alpha-synuclein inhibitors are a class of investigational therapies targeting the pathological aggregation of alpha-synuclein, a protein implicated i ...

Director Lars von Trier has been admitted to a care centre to receive treatment following Parkinson’s diagnosis. The Dancer ...

New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study ...

Along the difficult journey of gravely ill patients and families, palliative care provides holistic support and empowers them ...

Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.

AB-1002 is an investigational gene therapy for the treatment of adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) Class III heart failure symptoms GenePHIT is a clinical ...

AB-1002 is an investigational gene therapy for the treatment of adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) ...